Etiket: Biologics
Exscientia Expands Biologics Development Capabilities with Automated Laboratory
shares in this article Exscientia plc (Nasdaq: EXAI) today announced the expansion of its platform to include biologics development, e.g. B. of human antibodies. During the year, the company further…